F. Platt

发表

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.

Olivia Alder, Alastair Droop, Lucy F. Stead, 2017, Cancer cell.

Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis

C. Taylor, M. Knowles, C. Hurst, 2012, Clinical Cancer Research.

Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile, Clinical Outcome and Female Gender Bias in KDM6A Mutation Frequency

Lucy F. Stead, D. Gordenin, L. Klimczak, 2017 .

In-depth phenotyping for clinical stratification of Gaucher disease

K. Poole, R. Lachmann, A. Mehta, 2021, Orphanet Journal of Rare Diseases.

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine.

M. Knowles, C. Hurst, F. Platt, 2014, European urology.

Human Cancer Biology Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder De fi ned by Integrated Genomic Analysis

C. Taylor, M. Knowles, C. Hurst, 2012 .

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

M. Knowles, C. Hurst, F. Platt, 2009, Cancer and Metastasis Reviews.

Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer

W. Gregory, C. Taylor, M. Knowles, 2009, Clinical Cancer Research.

In-depth phenotyping for clinical stratification of Gaucher disease

Rishi Sharma, K. Poole, R. Lachmann, 2021, Orphanet Journal of Rare Diseases.

Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro

M. Knowles, J. Burns, C. Hurst, 2022, The Journal of pathology.

Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling

M. Knowles, J. Burns, C. Hurst, 2022, The journal of pathology. Clinical research.

AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K

H Snowden, M. Knowles, F. Platt, 2010, Oncogene.

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight

Mauro A. A. Castro, A. G. Robertson, I. Martincorena, 2021, Cell reports. Medicine.

High‐resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma

M. Knowles, C. Hurst, F. Platt, 2010, Genes, chromosomes & cancer.

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer

M. Knowles, C. Hurst, F. Platt, 2013, British Journal of Cancer.

Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase‐immortalized urothelial cells (TERT‐NHUC)

M. Knowles, C. Hurst, F. Platt, 2009, Genes, chromosomes & cancer.

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification

M. Knowles, C. Hurst, F. Platt, 2008, Oncogene.

Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms

M. Knowles, F. Platt, E. Morrison, 2008, Human Molecular Genetics.

Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes

C. Taylor, M. Knowles, C. Hurst, 2013, Human molecular genetics.

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA‐binding activities

A. Kiltie, C. Taylor, M. Knowles, 2009, Genes, chromosomes & cancer.

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.

Lucy F. Stead, D. Gordenin, L. Klimczak, 2017, Cancer cell.